ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : DRUG ACTION
Australian State/Territory : ACT
Australian State/Territory : NSW
Clear All
Filter by Field of Research
Epistemology (2)
Philosophy (2)
Basic Pharmacology (1)
Haematology (1)
Medical biochemistry - carbohydrates (1)
Molecular Targets (1)
Oncology And Carcinogenesis (1)
Philosophical Psychology (incl. Moral Psychology and Philosophy of Action) (1)
Philosophical psychology (incl. moral psychology and philosophy of action) (1)
Social and Community Psychology (1)
Filter by Socio-Economic Objective
Expanding Knowledge In Philosophy and Religious Studies (1)
Expanding Knowledge in Philosophy and Religious Studies (1)
Expanding Knowledge in Psychology and Cognitive Sciences (1)
Filter by Funding Provider
National Health and Medical Research Council (5)
Australian Research Council (2)
Filter by Status
Closed (5)
Active (2)
Filter by Scheme
Project Grants (3)
Discovery Projects (2)
NHMRC Project Grants (2)
Filter by Country
Australia (6)
Filter by Australian State/Territory
ACT (6)
NSW (6)
QLD (2)
VIC (1)
WA (1)
  • Researchers (1)
  • Funded Activities (7)
  • Organisations (0)
  • Funded Activity

    Melanotransferrin: A “Missing Link” And A Novel Pharmacological Target For Treatment

    Funder
    National Health and Medical Research Council
    Funding Amount
    $613,848.00
    Summary
    Despite >30 years of research, the precise function of the protein, melanotransferrin (MTf), is unknown. However, we have breakthrough evidence that MTf stimulates WNT signalling as a major driver in cancer progression. We will investigate this hypothesis, which will underpin new cancer therapies. Indeed, we designed a new class of drugs that target the WNT pathway via up-regulating the WNT inhibitor, NDRG1. This drug (DpC) inhibits MTf expression to block tumour cell growth and metastasis.
    More information
    Active Funded Activity

    Discovery Projects - Grant ID: DP240100914

    Funder
    Australian Research Council
    Funding Amount
    $478,013.00
    Summary
    Trust and Distrust in Social Epistemic Networks. This project aims to discover critically-needed understandings of the social causes and consequences of ‘fake news’. It will do this by investigating and mapping the relationship between ‘epistemic vices’ and people’s acceptance of misinformation and disinformation (e.g. conspiracy theories). It will bring together approaches from experimental philosophy, natural language processing, social network analysis, and normative reflection to provide new .... Trust and Distrust in Social Epistemic Networks. This project aims to discover critically-needed understandings of the social causes and consequences of ‘fake news’. It will do this by investigating and mapping the relationship between ‘epistemic vices’ and people’s acceptance of misinformation and disinformation (e.g. conspiracy theories). It will bring together approaches from experimental philosophy, natural language processing, social network analysis, and normative reflection to provide new insights regarding distrust and intellectual vice, thus significantly advancing knowledge of the ‘dark side’ of social epistemology. Results will lead to urgently required guidance regarding the features of social networks that exacerbate or buffer against the manifestation of these vices.
    Read more Read less
    More information
    Funded Activity

    Heparin-induced Thrombocytopenia And Thrombosis: Better Understanding Of Pathogenesis And Improving Diagnosis And Treatment

    Funder
    National Health and Medical Research Council
    Funding Amount
    $653,137.00
    Summary
    Heparin, a widely used drug, can cause an adverse effect which results in a fall of the platelet count and the development of serious thrombosis. This drug complication is mediated by an immune mechanism. This proposal aims to provide a better understanding of the disease mechanism. It also aims to develop a new test that will improve the diagnosis, and to produce a novel drug that will effectively suppress the immune reaction and improve the treatment.
    More information
    Active Funded Activity

    Discovery Projects - Grant ID: DP190101507

    Funder
    Australian Research Council
    Funding Amount
    $300,000.00
    Summary
    Trust in a social and digital world. This project aims to provide a systematic and empirically-informed account of the way networks facilitate or hinder knowledge. Distinguishing on-line information from disinformation can be difficult. This task can be greatly assisted by networks of trusted peers, but figuring out who to trust is itself a challenge. Identifying, designing, and facilitating networks of trust is therefore an urgent task. By using the tools of social epistemology, virtue epistemo .... Trust in a social and digital world. This project aims to provide a systematic and empirically-informed account of the way networks facilitate or hinder knowledge. Distinguishing on-line information from disinformation can be difficult. This task can be greatly assisted by networks of trusted peers, but figuring out who to trust is itself a challenge. Identifying, designing, and facilitating networks of trust is therefore an urgent task. By using the tools of social epistemology, virtue epistemology, and network science, this project will identify how individuals should distribute their trust when embedded in epistemically hostile environments.
    Read more Read less
    More information
    Funded Activity

    Pharmacology Of Potential Anti-Tumour Agents: Iron Chelators Of The BpT Class

    Funder
    National Health and Medical Research Council
    Funding Amount
    $585,455.00
    Summary
    Pharmacology of Potential Anti-Tumour Agents: Iron Chelators of the BpT Class Cancer cells have a high iron requirement for DNA synthesis and many clinical trials showed Fe chelators are effective anti-cancer drugs. Their potential to act as anti-tumour agents has been confirmed by the entrance of Triapine into widespread NCI clinical trials. In this NHMRC Renewal, we will perform pharmacological and preclinical studies to promote the development of BpT chelators as novel anti-tumour agents.
    More information
    Funded Activity

    ADAM Metalloprotease Inhibition For Treatment Of Colorectal Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $770,925.00
    Summary
    Colorectal cancer (CRC) causes over 4000 deaths/year, typically from developing drug resistance and spreading to other organs (metastasis). These processes involve tumour cells called cancer stem cells (CSCs), which rely on specific cell surface proteins for survival and function. We are developing antibodies against one of these type of proteins, to test in mouse models of CRC. These already show promise in targeting CSCs and inhibiting drug-resistance and metastasis in mice.
    More information
    Funded Activity

    Mechanisms Of Glucocorticoid Resistance In Acute Lymphoblastic Leukaemia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $547,970.00
    Summary
    Glucocorticoids are extremely active drugs used in the treatment of childhood acute lymphoblastic leukaemia (ALL), yet a proportion of patients respond poorly to therapy and exhibit resistance at relapse. Clinically relevant mechanisms of glucocorticoid resistance are poorly understood, principally due to lack of appropriate experimental models. This project will reveal novel mechanisms of drug resistance in childhood leukaemia and lead to novel therapeutic strategies to improve outcome.
    More information

    Showing 1-7 of 7 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback